Testing Treatment for Breast Cancer
common.study.values.description
“Stereotactic Body Radiotherapy for Patients With Breast Cancer Oligometastasis”
The purpose of this study is to evaluate feasibility to treat metachronous multi-site breast cancer oligometastasis with stereotactic body radiotherapy (SBRT) in patients on systemic therapy.
common.study.values.location
participant.ui.study.affiliations-map.online-study.header-virtual
participant.ui.study.affiliations-map.online-study.text
common.study.values.methods
 common.study.methods.has-drugs-no
                                        common.study.methods.has-drugs-no
                                 common.study.methods.is-healthy-yes
                                        common.study.methods.is-healthy-yes
                                Radiation - Stereotactic Body Radiotherapy
Five fraction SBRT (or two fraction in case of spine) to any sites of breast cancer oligometastasis using robotic radio surgery or linear accelerator based SBRT
participant.views.study.view.additional
participant.views.study.view.scientific-title
Stereotactic Body Radiotherapy (SBRT) for the Treatment of OligoMetastasis in Breast Cancer Patients (STOMP): A Prospective Feasibility Trial
common.study.values.clinical-trial-id
NCT03295916
participant.views.study.view.id
1aKDrb
 
    
    